Ocular Therapeutix, Inc.
OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
Last updated:
Abstract:
The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
Status:
Application
Type:
Utility
Filling date:
24 Mar 2021
Issue date:
7 Oct 2021